Cargando…
Exploring antibody repurposing for COVID-19: beyond presumed roles of therapeutic antibodies
The urgent need for a treatment of COVID-19 has left researchers with limited choice of either developing an effective vaccine or identifying approved/investigational drugs developed for other medical conditions for potential repurposing, thus bypassing long clinical trials. In this work, we compare...
Autores principales: | Rawat, Puneet, Sharma, Divya, Srivastava, Ambuj, Janakiraman, Vani, Gromiha, M. Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119408/ https://www.ncbi.nlm.nih.gov/pubmed/33986382 http://dx.doi.org/10.1038/s41598-021-89621-6 |
Ejemplares similares
-
Exploring the sequence features determining amyloidosis in human antibody light chains
por: Rawat, Puneet, et al.
Publicado: (2021) -
COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics
por: Yesudhas, Dhanusha, et al.
Publicado: (2020) -
A novel hybrid SEIQR model incorporating the effect of quarantine and lockdown regulations for COVID-19
por: Prabakaran, R., et al.
Publicado: (2021) -
Understanding the mutational frequency in SARS-CoV-2 proteome using structural features
por: Rawat, Puneet, et al.
Publicado: (2022) -
Deciphering the Role of Residues Involved in Disorder-To-Order Transition Regions in Archaeal tRNA Methyltransferase 5
por: Srivastava, Ambuj, et al.
Publicado: (2021)